This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Fresenius Medical Care AG & Co.Q2 2010 Earnings Call Transcript

Fresenius Medical Care AG & Co. (FMS)

Q2 2010 Earnings Call

August 3, 2010 09:30 am ET

Executives

Oliver Maier - SVP, Head - IR

Ben Lipps - Chairman and CEO

Mike Brosnan - CFO

Analysts

Kevin Ellich - RBC Capital Markets

Andreas Dirnagl - Stevens Incorporated

Tom Jones - Berenberg Bank

Lisa Clive - Sanford Bernstein

Michael Jungling - Morgan Stanley

Ilan Chaitowitz - Redburn Partners

Stephan Gasteyger - Jefferies

Martin Wales - UBS

Ann Wireheim - Invesco

Justin Lake - UBS

Martin Whitbread - Credit Suisse

Rosanna Burcheri - FrontPoint Partners

Presentation

Oliver Maier

Good afternoon and good morning everybody. I would like to welcome you to our second quarter and first-half year results conference call. I am joined today by Ben Lipps our Chairman and CEO. Ben would address our strategic priorities and give us a general business update and our Chief Financial Officer; Mike Brosnan who will then discusses our second quarter and first-half results in greater detail and addresses our growth outlook for the full-year.

We will use slides for the presentations today which has been posted on our website and link will sent to you separately by e-mail. I would like to remind you that our comments today will be gathering to our Safe Harbor statement. So the course of our presentation today we make certain forward-looking statements and actual results could vary materially. We will use non-GAAP financial measures to help you to understand our underlying business performance although the GAAP reconciliations are provided in our investor news.

So with that actually I would like to turn the call over to Ben. Ben, it’s yours.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
FMS $41.93 -0.05%
AAPL $114.64 -3.21%
FB $94.06 -0.08%
GOOG $629.25 -0.31%
TSLA $266.28 2.42%

Markets

Chart of I:DJI
DOW 17,550.69 -47.51 -0.27%
S&P 500 2,093.32 -4.72 -0.22%
NASDAQ 5,105.5460 -9.8360 -0.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs